Offer - Urjas Oil for just ₹ 1 X
Lotepred T is a prescription drug, available for use as Drops. Secondary and off-label uses of Lotepred T have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Lotepred T. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Lotepred T side effects, there are can be others also. These have been listed below. Such side effects of Lotepred T normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Lotepred T has a Severe effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Lotepred T has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Lotepred T related warnings section.
Individuals suffering from medical conditions like Herpes, Kidney Disease must refrain from the use of Lotepred T since this can cause severe adverse effects. Other conditions have been mentioned below in the Lotepred T contraindications section.
Besides this, Lotepred T may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Lotepred T is safe while driving, and is is addictive in nature.
Lotepred T is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Lotepred T safe for pregnant women?
Lotepred T can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Lotepred T safe during breastfeeding?
Lotepred T may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Lotepred T, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Lotepred T.
What is the effect of Lotepred T on the Kidneys?
Lotepred T may have mild side effects on the kidneys.
What is the effect of Lotepred T on the Liver?
Using Lotepred T does not have any harmful effects on the liver.
What is the effect of Lotepred T on the Heart?
You can take Lotepred T without any fear of damage to the heart.
Lotepred T should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Lotepred T unless your doctor advises you to do so -
Is this Lotepred T habit forming or addictive?
No, there is no any evidence that Lotepred T is addictive.
Interaction between Food and Lotepred T
You can take Lotepred T with food.
Interaction between Alcohol and Lotepred T
It is difficult to say anything about the effect of Lotepred T and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lotemax® (loteprednol etabonate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1402
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tobramycin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-141